Simon M. Collin, PhD

Associate Director, Oncology Outcomes Research
AstraZeneca Pharmaceuticals Ltd, United Kingdom

Poster(s):

• (315) Economic burden of neutropenia among patients treated for HR+/HER2- and triple-negative metastatic breast cancer in the United States: a retrospective claims analysis
  Wednesday, October 29, 2025